Results 31 to 40 of about 1,716,389 (207)

The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases

Viruses, 2021
The oral poliovirus vaccine (OPV), which prevents person-to-person transmission of poliovirus by inducing robust intestinal immunity, has been a crucial tool for global polio eradication.
Kouichi Kitamura, Hiroyuki Shimizu
doaj   +1 more source

Intussusception and Oral Poliovirus Vaccination: Is There an Association? [PDF]

American Journal of Epidemiology, 2004
Oral rotavirus vaccine was voluntarily withdrawn from the market after studies observed an increased risk of intussusception within 2 weeks after immunization. Concern has been raised that other orally administered vaccines, such as oral poliovirus vaccine (OPV), may also be associated with intussusception.
Su-Ting T, Li, Robert L, Davis, Noel S, Weiss   +2 more
openaire   +2 more sources

Comprehensive Immunisation Among Children Aged 12-23 Months in India-A Multilevel Modelling Analysis From the National Family Health Survey (2015-21). [PDF]

Public Health Chall
ABSTRACT Under‐5 child mortality due to vaccine preventable diseases (VPDs) contributes to an estimated burden of ∼5.2 million deaths globally, mostly within low‐ and middle‐income countries (LMICs). Despite ongoing efforts to expand immunisation coverage, gaps in immunisation remain a persistent public health concern, underscoring the need to examine ...
Malik M, Basu S, Girotra S, Kundu S.
europepmc   +2 more sources

Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study [PDF]

, 2018
In 2015, several provinces in Lao People's Democratic Republic (Lao PDR) experienced a vaccine-derived poliovirus outbreak. This survey was conducted (i) to evaluate the vaccination coverage in different settings and cohorts using the seroprevalence of ...
Nouanthong, Phonethipsavanh, Nanthavong, Naphavanh, Samountry, Bounthome, Xeuatvongsa, Anonh, Sayasinh, Kong, Jutavijittum, Prapan, Khampanisong, Phonepaseuth, Hübschen, Judith M, Black, Antony P., Diedrich, Sabine, Pauly, Maude, Muller, Claude P.   +11 more
core   +1 more source

Low rates of repeat HIV testing despite increased availability of antiretroviral therapy in rural Tanzania: findings from 2003-2010. [PDF]

, 2013
BACKGROUND: HIV counselling and testing (HCT) services can play an important role in HIV prevention by encouraging safe sexual behaviours and linking HIV-infected clients to antiretroviral therapy (ART).
Mtenga, Baltazar, Todd Jim, Baltazar Mtenga, Wringe Alison, Marston, Milly, Cawley, Caoimhe, Clark, Benjamin, Caoimhe Cawley, Todd, Jim, Urassa, Mark, Isingo, Raphael, Isingo Raphael, Urassa Mark, Benjamin Clark, Milly Marston, Zaba Basia, Wringe, Alison, Alison Wringe, Clark Benjamin, Mark Urassa, Zaba, Basia, Marston Milly, Raphael Isingo, Cawley Caoimhe, Mtenga Baltazar, Basia Zaba, Jim Todd   +26 more
core   +1 more source

First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus

International Journal of Infectious Diseases, 2019
This is the first report of persistent oropharyngeal mucosal infection with type 2 poliovirus (iVDPV2) in a primary immune deficient patient (PID) after wild type 2 poliovirus eradication. The iVDPV2 also established persistence in the gut.
Merav Weil, Galia Rahav, Raz Somech, Tali Stauber, Jacqueline Alfandari, Leah Weiss, Ilana Silberstein, Victoria Indenbaum, Itay Bar Or, Ella Mendelson, Danit Sofer, Lester M. Shulman   +11 more
doaj   +1 more source

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy [PDF]

, 2012
INTRODUCTION: Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of safety data of the killed whole-cell oral cholera (rBS-WC) vaccine.
Jin Kyung Park (78612), Jacqueline L. Deen (148731), Mohammad Ali, Abdul A. Saleh, Saleh, A. A., Na Yoon Chang (148714), Rita Reyburn (130140), Stephen Obaro (148749), Sunheang Shin (148734), Anna Lena Lopez, Sack, D., Kamala Thriemer, Said M. Ali, Ramadhan Hashim (148699), Ahmed M. Khatib (130136), David Sack, Lorenz von Seidlein, Anna Lena Lopez (92298), Aguado, M. T., Raymond Hutubessy (130149), Godwin Enwere, Shaame, A. J., Ahmed M. Khatib, Maria Teresa Aguado (148740), Godwin Enwere (148705), Abdul A. Saleh (148759), Attiye J Shaame, Raymond Hutubessy, John D. Clemens, Park, J. K., Jacqueline L. Deen, Sunheang Shin, Said M Ali, Abdul A Saleh, Attiye J. Shaame, Mohammad Ali (73095), Jiddawi, M. S., Maria Teresa Aguado, Na Yoon Chang, Rita Reyburn, Lena Lopez, Schaetti, C., John D. Clemens (148728), Attiye J. Shaame (148753), Marie Paule Kieny, Khatib, A. M., Reyburn, R., Ley, B., Shin, S., Lopez, A. L., Mohamed S. Jiddawi (148765), Deok Ryun Kim, Stephen Obaro, Thriemer, K., Ahmed M Khatib, Jacqueline L Deen, Clemens, J. D., Kieny, M. P., Mohamed S Jiddawi, Ali, S. M., Hashim, R., John D Clemens, David Sack (148746), Enwere, G., Chang, N. Y., Deok Ryun Kim (78610), Ramadhan Hashim, Benedikt Ley, Mohamed S. Jiddawi, Ali, M., Deen, J. L., Benedikt Ley (148722), von Seidlein, L., Hutubessy, R., Christian Schaetti (130127), Kim, D. R., Christian Schaetti, Lorenz von Seidlein (45473), Kamala Thriemer (148725), Obaro, S., Marie Paule Kieny (148743), Said M. Ali (130132), Jin Kyung Park   +82 more
core   +2 more sources

: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023

, 2023
International audienceCirculating vaccine-derived poliovirus (cVDPV) outbreaks can occur when oral poliovirus vaccine strains (most often, Sabin monovalent oral poliovirus vaccine type 2 [mOPV2]) undergo prolonged circulation in undervaccinated ...
Henderson, Elizabeth, Kfutwah, Anfumbom, Maël Bessaud, Elizabeth Davlantes, Ousmane M. Diop, Bessaud, Maël, Bullard, Kelley, Simona Zipursky, Javier Martin, Jorba, Jaume, Mark. A. Deka, Burns, Cara, Diop, Ousmane, Kaija Hawes, Martin, Javier, Zipursky, Simona, Deka, Mark., Hawes, Kaija, Jaume Jorba, Elizabeth Henderson, Shulman, Lester, Cara C. Burns, Kelley Bullard, Anfumbom Kfutwah, Bandyopadhyay, Ananda, Ananda S. Bandyopadhyay, Lester M. Shulman   +26 more
core   +1 more source

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance [PDF]

, 2009
BACKGROUND: Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Khatib Ahmed M, Al Pach, Khatib, Ahmed M, Claire-Lise Chaignat, Schaetti, C., Ali Said M, Weiss, M. G., Hutubessy, Raymond, Weiss, Mitchell G, Khatib, A. M., Mitchell G Weiss, Hutubessy Raymond, Schaetti Christian, Ahmed M Khatib, Ali, S. M., Schaetti, Christian, Chaignat Claire-Lise, Ali, Said M, Pach, Al, Pach Al, Pach, A., Chaignat, Claire-Lise, Hutubessy, R., Chaignat, C. L., Raymond Hutubessy, Weiss Mitchell G, Christian Schaetti, Said M Ali   +27 more
core   +2 more sources

Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial

Human Vaccines & Immunotherapeutics, 2017
Background: The type 2 component of the oral poliovirus vaccine is targeted for global withdrawal through a switch from the trivalent oral poliovirus vaccine (tOPV) to a bivalent oral poliovirus vaccine (bOPV). The switch is intended to prevent paralytic
Jingjun Qiu, Yunkai Yang, Lirong Huang, Ling Wang, Zhiwei Jiang, Jian Gong, Wei Wang, Hongyan Wang, Shaohong Guo, Chanjuan Li, Shuyuan Wei, Zhaojun Mo, Jielai Xia   +12 more
doaj   +1 more source